Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
UTI Mutual Fund

UTI Healthcare Fund Direct-Growth

NAV
returns change indicator
184.5215
as on 21 Sep 2021, 11:15 PM
1.5080(0.82%)
Last Change
loaderloader

Schemes Managed By

Start SIP in this Mutual Fund

Min SIP Amount
500
Suggested Date
22nd of Every Month

Investment Performance

would have given a return of
1,10,871
star
1,21,647
star
1,80,961
star
1,86,366
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
86,366
Profit (absolute return)
86.37%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
6.37%
In the last 6 months
26.83%
In the last 1 year
28.47%
In the last 3 years
86.37%
In the last 5 years
85.41%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
low to moderate
low to moderate
moderate
moderate
moderately high
moderately high
high
high
very high
very high
indicator
Investors understand that their principal will be at very high risk

Scheme Information

UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth
as of 31 Aug 2021, 05:30 AM
897.05 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 30 days.
1.28%
Expense Ratio
Plan
Growth
2.69%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 30 days.
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Aug 2021
Sort By
Healthcare
95.27%
854.62 Cr
Cash Holding
2.69%
24.13 Cr
FMCG
2.04%
18.30 Cr

Companies Holding in this Mutual Fund

as on 31 Aug 2021
Sort By
Dr. Reddy's Laboratories Ltd.
8.74%
78.40 Cr
Sun Pharmaceutical Industries Ltd.
8.12%
72.84 Cr
Cipla Ltd.
7.61%
68.27 Cr
Aurobindo Pharma Ltd.
6.97%
62.52 Cr
Divi's Laboratories Ltd.
5.70%
51.13 Cr
Fortis Healthcare Ltd.
4.80%
43.06 Cr
Ajanta Pharma Ltd.
4.63%
41.53 Cr
Eris Lifesciences Ltd
4.55%
40.82 Cr
JB Chemicals & Pharmaceuticals Ltd.
3.89%
34.90 Cr
FDC Ltd.
3.82%
34.27 Cr
View All
View All

About UTI Healthcare Fund Direct-Growth

UTI Healthcare Fund Direct-Growth is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager V Srivatsa. It has an AUM of ₹897.05 Crores and the latest NAV decalared is ₹184.522 as on 22 Sep 2021 at 1:27 am.
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 28.47%, in last 3 years is 86.37% and 286.68% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.

Scheme Details

AUM:897.05 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

AMC Information

UTI Mutual Fund
UTI Mutual Fund
View AMC Details
2,13,135.24 Cr
AUM
207
Schemes
Address
Address
UTI Tower, 'GN' Block,Bandra-Kurla Complex,Bandra (East),400051
Phone Number
Phone Number
Phone : 022- 66786666 / 66786354 / 1800-22-1230
Fax : 022-26523031